*This* Is Why Cops Should Open Fire on Drivers Who Try to Run...
Guess Who Iran's Supreme Leader Blames for Nationwide Unrest
Taking Action on Walz’s Minnesota Fraud Scandal
Nebraska Democrat Tears Down Patriotic Exhibit As America Prepares for 250th Birthday
The U.S. Has Seized Another Tanker of Embargoed Venezuelan Oil
Target Hasn't Completely Dumped the Woke Nonsense
Oregon Democrats Defend Violent Venezuelan Gang Member After Another ICE-Involved Shooting...
Venezuelans Are Trolling Maduro in Prison, and It's Glorious
'Seeking Peace:' President Trump Reports Venezuela Is Releasing 'Large Number' of Politica...
Wisconsin Man Pleads Guilty After Killing Parents to Finance Trump Assassination Plan
In Mamdani's New York, Cheering for Hamas Is Now the Norm
Kamikaze Leftists: Desperation in the Age of DOGE
Mamdani and Allies Rally Behind Controversial Tenant Director Pick After Racist Posts Resu...
Woman Shot by ICE Agent Identified As Member of Radical 'ICE Watch' Group...
The December Jobs Report Is Here
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement